Breaking News

WuXi PharmaTech Completes St. Paul Facility Expansion

May 12, 2014

Expands materials characterization testing services in St. Paul

WuXi PharmaTech, Inc. has completed the expansion of its materials characterization testing facility in St. Paul, MN. The new lab will begin operations by the end of June. 
 
The new 20,000-sq.-ft. lab will offer expanded capacity for existing services, such as particle identification and extractable/leachable testing, and its new service, dynamic light scattering for nanoparticle characterization. The expansion is designed to allow rapid scale-up of technologies to increase capacities for chemical analysis of medical materials.  
 
"WuXi is committed to helping medical device and biologics companies bring their products to market faster," said Dr. Ge Li, chairman and chief executive officer of WuXi PharmaTech. "This facility and WuXi's trained staff will better serve our customers' growing need to quantify the chemical safety of materials used in medical devices and biologics."
blog comments powered by Disqus
  • CMO Systems

    CMO Systems

    Philip K. Burns, CRO Consulting||April 5, 2016
    A CMO system includes four aspects of the product lifecycle: regulatory, technical, compliance, and operations.

  • Continuous Pharmaceutical Processes and Their Demands

    Continuous Pharmaceutical Processes and Their Demands

    Girish Malhotra, EPCOT International||April 5, 2016
    A look at the unique characteristics of continuous processes in pharmaceutical manufacturing.

  • Newsmakers: Ian Muir

    Tim Wright, Editor||April 5, 2016
    End-to-End Service